Product Information
INVEGA TRINZA 410 MG/1.32 ML is a brand product labeled by Janssen Pharmaceuticals Inc., priced at $3959.9762 per ML under NDC 50458060701. Its NADAC has been published 414 times since Jun 20, 2018.
FDA first approved this application on May 18, 2015.
Strength
410 mg/1.32mL
Manufacturer
Janssen Pharmaceuticals Inc.NDC
50458060701
Classification
Brand
Dosage Form
INJECTION, SUSPENSION, EXTENDED RELEASE
Route
INTRAMUSCULAR
Effective Date
8/19/2026
Active Ingredients
PALIPERIDONE PALMITATEApproval Type
New Drug (NDA)
FDA Application
NDA207946FDA Approved
5/18/2015
On Market Since
5/19/2015
Pharmacological Classes
Price Statistics
The NADAC for INVEGA TRINZA 410 MG/1.32 ML has been published 414 times since Jun 20, 2018, and over the history we have for it it has risen 44.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $3959.9762 per ML |
|---|---|
| All-time high | $3973.3790 (Jul 15, 2026) |
| All-time low | $2743.7703 (Jun 20, 2018) |
| 52-week high | $3973.3790 |
| 52-week low | $3871.1226 |
| Median price | $3367.1885 |
| Average price | $3422.8093 |
| Largest weekly change | +6.9% (Jan 16, 2019) |
| Weeks tracked | 414 |
| Tracking since | Jun 20, 2018 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the paliperidone palmitate market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of INVEGA TRINZA 410 MG/1.32 ML?
The current National Average Drug Acquisition Cost (NADAC) for INVEGA TRINZA 410 MG/1.32 ML, manufactured by Janssen Pharmaceuticals Inc., is $3959.9762 per ML (NDC 50458060701), effective Aug 19, 2026.
How has the price of INVEGA TRINZA 410 MG/1.32 ML changed over time?
Over the history we have for it, the NADAC for INVEGA TRINZA 410 MG/1.32 ML has risen 44.3%. It has been tracked across 414 weekly CMS publications since Jun 20, 2018.
What are the highest and lowest recorded NADAC prices for INVEGA TRINZA 410 MG/1.32 ML?
Since Jun 20, 2018, the NADAC for INVEGA TRINZA 410 MG/1.32 ML has ranged from a low of $2743.7703 (Jun 20, 2018) to a high of $3973.3790 (Jul 15, 2026), with a median of $3367.1885 per ML.
Are there cheaper alternatives to INVEGA TRINZA 410 MG/1.32 ML?
No other NADAC-published product currently shares the active ingredient and strength of INVEGA TRINZA 410 MG/1.32 ML in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures INVEGA TRINZA 410 MG/1.32 ML?
INVEGA TRINZA 410 MG/1.32 ML (NDC 50458060701) is labeled by Janssen Pharmaceuticals Inc., and CMS classifies it as a brand product.